Myelin, Oligodendrocyte Glycoprotein, 44-54 (OMgp, MOG)
Catalog No : USB-M9758-08E
331.04€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Myelin, Oligodendrocyte Glycoprotein, 44-54 (OMgp, MOG) | ||
|---|---|---|---|
| Catalog No | USB-M9758-08E | ||
| Supplier’s Catalog No | M9758-08E | ||
| Supplier | US Biologicals | ||
| Source antigen | |||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 1347.6 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~90% as determined by RP-HPLC, MS | ||
| Form | Supplied as a lyophilized powder without additives. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | ~90% as determined by RP-HPLC, MS | ||
| Description | This 11mer peptide myelin oligodendrocyte glycoprotein ( pMOG) (44–54) represents the core binding epitope for MOG-specific CD8+ T cells. This is the minimal, functionally constant, length of the MOG (35–55) peptide that binds to CD8+ MOG-specific T cells and stimulates T cell proliferation in vitro. MOG peptide (35-55) is highly encephalitogenic and can induce strong T and B cell responses. A single injection of this peptide produces a relapsing- remitting neurologic disease with extensive plaque-like demyelination. Because of the clinical, histophathologic, and immunologic similarities with multiple sclerosis (MS), the MOG induced demyelinating encephalomyelitis may serve as a model for investigating MS. Amino Acid Composition: H-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-OH. Solubility: It is recommended to reconstitute the lyophilized MOG in sterile 18MΩ-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions. Storage and Stability: Lyophilized powder may be stored at 4°C for short-term only. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved